Brooks Laboratories is currently trading at Rs. 87.10, up by 0.80 points or 0.93% from its previous closing of Rs. 86.30 on the BSE.
The scrip opened at Rs. 89.00 and has touched a high and low of Rs. 90.00 and Rs. 86.00 respectively. So far 16,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 152.60 on 21-Apr-2017 and a 52 week low of Rs. 82.50 on 09-Mar-2018.
Last one week high and low of the scrip stood at Rs. 90.00 and Rs. 83.00 respectively. The current market cap of the company is Rs. 140.98 crore.
The promoters holding in the company stood at 60.62%, while Institutions and Non-Institutions held 0.14% and 39.25% respectively.
Brooks Laboratories has received WHO-GMP certificate for its Vadodara facility. Earlier in February, the company had received EU-GMP certificate for its Vadodara facility.
Brooks Laboratories is a Research and Development driven Pharmaceutical manufacturing company, in last 6 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |